524632
SHUKRAPHAR
Start SIP
Invest Now
Start SIP in SHUKRAPHAR
Performance
- Low
- ₹47
- High
- ₹49
- 52 Week Low
- ₹12
- 52 Week High
- ₹65
- Open Price₹48
- Previous Close₹50
- Volume205,525
- 50 DMA₹47.88
- 100 DMA₹40.86
- 200 DMA₹32.37
Investment Returns
- Over 1 Month + 6.94%
- Over 3 Month + 42.99%
- Over 6 Month + 141.7%
- Over 1 Year + 161.62%
Smart Investing Starts Here Start SIP with Shukra Pharmaceuticals for Steady Growth!
Shukra Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 173.2
- PEG Ratio
- -10.1
- Market Cap Cr
- 2,071
- P/B Ratio
- 31.5
- Average True Range
- 3.48
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- 2.97
- RSI
- 41.72
- MFI
- 51.58
Shukra Pharmaceuticals Financials
Shukra Pharmaceuticals Technicals
EMA & SMA
Current Price
₹47.30
-2.48
(-4.98%)
- Bearish Moving Average 10
- Bullish Moving Average 6
- 20 Day
- ₹52.87
- 50 Day
- ₹47.88
- 100 Day
- ₹40.86
- 200 Day
- ₹32.37
Resistance and Support
47.7
- R3 49.30
- R2 48.90
- R1 48.10
- S1 46.90
- S2 46.50
- S3 45.70
Shukra Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-13 | Quarterly Results | |
| 2025-10-03 | Others | Inter-alia, to consider 1. To declare and fix relevant date for the Pproposed preferential issue. 2. fix day, date, time and venue for Extra-ordinary General meeting (EGM). 3. Other business matters. alia, 1. To consider in principle, the issue of equity shares of face value of Rs. 10/- each on a rights basis ("Rights Issue") to the shareholders of the Company. |
| 2025-08-13 | Quarterly Results | |
| 2025-06-04 | Final Dividend | |
| 2025-05-29 | Audited Results |
Shukra Pharmaceuticals F&O
About Shukra Pharmaceuticals
- NSE Symbol
- SHUKRAPHAR
- BSE Symbol
- 524632
- Managing Director
- Mr. Dakshesh Rameshchandra Shah
- ISIN
- INE551C01044
Similar Stocks to Shukra Pharmaceuticals
Shukra Pharmaceuticals FAQs
Shukra Pharmaceuticals share price is ₹47 As on 11 January, 2026 | 03:39
The Market Cap of Shukra Pharmaceuticals is ₹2071.2 Cr As on 11 January, 2026 | 03:39
The P/E ratio of Shukra Pharmaceuticals is 173.2 As on 11 January, 2026 | 03:39
The PB ratio of Shukra Pharmaceuticals is 31.5 As on 11 January, 2026 | 03:39
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.